Panacea Innovation Ltd → Connect Biopharma Holdings Ltd CNTB

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 2.78

2,062,435 shares short · +55.4% vs prior

Other 13D/G Filings on Connect Biopharma Holdings Ltd

Filed	Form	Filer	Stake	Shares
2026-04-01	SCHEDULE 13D/A	Panacea Innovation Ltd	21.20%	13,160,000	view →
2025-07-21	SCHEDULE	Panacea Innovation Ltd	25.10%	13,950,000	view →
2021-06-07	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →

Other Filings by Panacea Innovation Ltd

Filed	Form	Issuer	Stake	Shares
2026-05-11	SCHEDULE 13D/A	Atara Biotherapeutics, Inc. ATRA	—	1,318,894	view →
2026-04-01	SCHEDULE 13D/A	Connect Biopharma Holdings Limited CNTB	21.20%	13,160,000	view →
2025-07-21	SCHEDULE	Connect Biopharma Holdings Ltd CNTB	25.10%	13,950,000	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →